Cancer and interstitial lung disease

Current Opinion in Pulmonary Medicine

Volumn 10, Issue 5, 2004, Pages 425-434

  Artinian, Vasken ^a   Kvale, Paul A ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Cancer; Collagen vascular disease; Interstitial lung disease; Pneumoconiosis; Pulmonary fibrosis; Sarcoidosis

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADENOCARCINOMA; ASBESTOSIS; BERYLLIOSIS; BLADDER CANCER; BREAST CANCER; BRONCHOPLEURAL FISTULA; CANCER INCIDENCE; CANCER RISK; CANCER SURGERY; CIGARETTE SMOKING; COAL WORKER; COLORECTAL CANCER; DERMATOMYOSITIS; DIGESTIVE SYSTEM CANCER; EPIDEMIOLOGICAL DATA; EPSTEIN BARR VIRUS; HEMATOLOGIC MALIGNANCY; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; KIDNEY CANCER; LARYNX CANCER; LUNG CANCER; LUNG CARCINOGENESIS; LUNG COMPLICATION; LUNG FIBROSIS; LYMPHOMA; MESOTHELIOMA; OVARY CANCER; PNEUMOCONIOSIS; PNEUMONIA; POINT MUTATION; POLYMYOSITIS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SILICOSIS; SJOEGREN SYNDROME; SQUAMOUS CELL CARCINOMA; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TUMOR SUPPRESSOR GENE; VIRUS INFECTION; WEGENER GRANULOMATOSIS;

EID: 4143084844     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200409000-00017     Document Type: Review

References (125)

1. Kawai T, Yakumaru K, Suzuki M, et al.: Diffuse interstitial pulmonary fibrosis and lung cancer. Acta Pathol Jpn 1987, 37:11-19.
2. Fraire AE, Greenberg SD: Carcinoma and diffuse interstitial fibrosis of lung. Cancer 1973, 31:1078-1086.
3. Haddad R, Massaro D: Idiopathic diffuse interstitial pulmonary fibrosis (fibrosing alveolitis), atypical epithelial proliferation and lung cancer. Am J Med 1968, 45:211-219.
4. Turner-Warwick M, Lebowitz M, Burrows B, et al.: Cryptogenic fibrosing alveolitis and lung cancer. Thorax 1980, 35:496-499.
5. Friedrich G: Periphere Lungenkrebse auf dem Bodem pleuranaher. Virchow's Arch Path Anat 1939:230.
6. Hironaka M, Fukayama M: Pulmonary fibrosis and lung carcinoma: a comparative study of metaplastic epithelia in honeycombed areas of usual interstitial pneumonia with or without lung carcinoma. Pathol Int 1999, 49:1060-1066.
7. Jacobson DR, Fishman CL, Mills NE: Molecular genetic tumor markers in the early diagnosis and screening of non-small-cell lung cancer. Ann Oncol 1995, 6(Suppl 3):S3-S8.
8. Kuwano K, Kunitake R, Kawasaki M, et al.: P21 Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1996, 154:477-483.
9. Kunitake R, Kuwano K, Miyazaki H, et al.: Expression of p53, p21 (Waf1/Cip1/Sdi1) and Fas antigen in collagen vascular and granulomatous lung diseases. Eur Respir J 1998, 12:920-925.
10. Kastan MB, Onyekwere O, Sidransky D, et al.: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991, 51:6304-6311.
11. Lowe SW, Schmitt EM, Smith SW, et al.: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993, 362:847-849.
12. Hojo S, Fujita J, Yamadori I, et al.: Heterogeneous point mutations of the p53 gene in pulmonary fibrosis. Eur Respir J 1998, 12:1404-1408.
13. Vassilakis DA, Sourvinos G, Spandidos DA, et al.: Frequent genetic alterations at the microsatellite level in cytologic sputum samples of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2000, 162:1115-1119.
14. Uematsu K, Yoshimura A, Gemma A, et al.: Aberrations in the fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis. Cancer Res 2001, 61:8527-8533.
15. Nagai A, Chiyotani A, Nakadate T, Konno K: Lung cancer in patients with idiopathic pulmonary fibrosis. Tohoku J Exp Med 1992, 167:231-237.
16. Wells C, Mannino DM: Pulmonary fibrosis and lung cancer in the United States: analysis of the multiple cause of death mortality data, 1979 through 1991. South Med J 1996, 89:505-510.
17. Matsushita H, Tanaka S, Saiki Y, et al.: Lung cancer associated with usual interstitial pneumonia. Pathol Int 1995, 45:925-932.
18. Baumgartner KB, Samet JM, Stidley CA, et al.: Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997, 155:242-248.
19. Hubbard R, Venn A, Lewis S, Britton J: Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 2000, 161:5-8.
20. Aubry MC, Myers JL, Douglas WW, et al.: Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis. Mayo Clin Proc 2002, 77:763-770.
21. Lee HJ, Im JG, Ahn JM, et al.: Lung cancer in patients with idiopathic pulmonary fibrosis: CT findings. J Comput Assist Tomogr 1996, 20:979-982.
22. Mizushima Y, Kobayashi M: Clinical characteristics of synchronous multiple lung cancer associated with idiopathic pulmonary fibrosis: a review of Japanese cases. Chest 1995, 108:1272-1277.
23. Kawasaki H, Nagai K, Yokose T, et al.: Clinicopathological characteristics of surgically resected lung cancer associated with idiopathic pulmonary fibrosis. J Surg Oncol 2001, 76:53-57.
24. Kawasaki H, Nagai K, Yoshida J, et al.: Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis. J Surg Oncol 2002, 81:33-37.
25. Kumar P, Goldstraw P, Yamada K, et al.: Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg 2003, 125:1321-1327.
26. Brincker H, Wilbek E: The incidence of malignant tumors in patients with sarcoidosis. Ugeskr Laeger 1974, 136:2192-2195.
27. Newman LS, Rose CS, Maier LA: Sarcoidosis. N Engl J Med 1997, 336:1224-1234.
28. Romer F: Sarcoidosis and cancer. New York: Marcel Dekker, 1994.
29. Laurberg P: Sarcoid reactions in pulmonary neoplasms. Scand J Respir Dis 1975, 56:20-27.
30. Sacks EL, Donaldson SS, Gordon J, et al.: Epithelioid granulomas associated with Hodgkin's disease: clinical correlations in 55 previously untreated patients. Cancer 1978, 41:562-567.
31. Romer F: Sarcoidosis and cancer: a critical review. In Eighth International Conference on Sarcoidosis and Other Granulomatous Diseases. Cardiff, Wales: Alpha Omega, 1980:567-571.
32. Reich JM, Mullooly JP, Johnson RE: Linkage analysis of malignancy-associated sarcoidosis. Chest 1995, 107:605-613.
33. Seersholm N, Vestbo J, Viskum K: Risk of malignant neoplasms in patients with pulmonary sarcoidosis. Thorax 1997, 52:892-894.
34. Romer FK, Hommelgaard P, Schou G: Sarcoidosis and cancer revisited: a long-term follow-up study of 555 Danish sarcoidosis patients. Eur Respir J 1998, 12:906-912.
35. Askling J, Grunewald J, Eklund A, et al.: Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 1999, 160:1668-1672.
36. Hill CL, Nguyen AM, Roder D, et al.: Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 2003, 62:728-731.
37. Abu-Shakra M, Guillemin F, Lee P: Cancer in systemic sclerosis. Arthritis Rheum 1993, 36:460-464.
38. Roumm AD, Medsger TA Jr: Cancer and systemic sclerosis: an epidemiologic study. Arthritis Rheum 1985, 28:1336-1340.
39. Black KA, Zilko PJ, Dawkins RL, et al.: Cancer in connective tissue disease. Arthritis Rheum 1982, 25:1130-1133.
40. Rosenthal AK, McLaughlin JK, Linet MS, et al.: Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis 1993, 52:531-533.
41. Rosenthal AK, McLaughlin JK, Gridley G, et al.: Incidence of cancer among patients with systemic sclerosis. Cancer 1995, 76:910-914.
42. Peters-Golden M, Wise RA, Hochberg M, et al.: Incidence of lung cancer in systemic sclerosis. J Rheumatol 1985, 12:1136-1139.
43. Higuchi M, Horiuchi T, Ishibashi N, et al.: Anticentromere antibody as a risk factor for cancer in patients with systemic sclerosis. Clin Rheumatol 2000, 19:123-126.
44. Hazleman B: Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens. Am J Med 1985, 78:39-43.
45. Sakkas LI, Moore DF, Akritidis NC: Cancerin families with systemic sclerosis. Am J Med Sci 1995, 310:223-225.
46. Prior P: Cancer and rheumatoid arthritis: epidemiologic considerations. Am J Med 1985, 78:15-21.
47. Gridley G, McLaughlin JK, Ekbom A, et al.: Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993, 85:307-311.
48. Isomaki HA, Hakulinen T, Joutsenlahti U: Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis 1978, 31:691-696.
49. Mellemkjaer L, Linet MS, Gridley G, et al.: Rheumatoid arthritis and cancer risk. Eur J Cancer 1996, 32A:1753-1757.
50. Thomas E, Brewster DH, Black RJ, et al.: Risk of malignancy among patients with rheumatic conditions. Int J Cancer 2000, 88:497-502.
51. Katusic S, Beard CM, Kurland LT, et al.: Occurrence of malignant neoplasms in the Rochester, Minnesota, rheumatoid arthritis cohort. Am J Med 1985, 78:50-55.
52. Cibere J, Sibley J, Haga M: Rheumatoid arthritis and the risk of malignancy. Arthritis Rheum 1997, 40:1580-1586.
53. Thomas E, Symmons DP, Brewster DH, et al.: National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J Rheumatol 2003, 30:958-965.
54. Berkel H, Holcombe RF, Middlebrooks M, et al.: Nonsteroidal antiinflammatory drugs and colorectal cancer. Epidemiol Rev 1996, 18:205-217.
55. Depper JM, Zvaifler NJ: Epstein-Barr virus: its relationship to the pathogenesis of rheumatoid arthritis. Arthritis Rheum 1981, 24:755-761.
56. Depper JM, Bluestein HG, Zvaifler NJ: Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect. J Immunol 1981, 127:1899-1902.
57. Kassan SS, Thomas TL, Moutsopoulos HM, et al.: Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978, 89:888-892.
58. Pariente D, Anaya JM, Combe B, et al.: Non-Hodgkin's lymphoma associated with primary Sjogren's syndrome. Eur J Med 1992, 1:337-342.
59. Kruize AA, Hene RJ, van der Heide A, et al.: Long-term followup of patients with Sjogren's syndrome. Arthritis Rheum 1996, 39:297-303.
60. Zufferey P, Meyer OC, Grossin M, et al.: Primary Sjogren's syndrome (SS) and malignant lymphoma: a retrospective cohort study of 55 patients with SS. Scand J Rheumatol 1995, 24:342-345.
61. Zulman J, Jaffe R, Talal N: Evidence that the malignant lymphoma of Sjogren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med 1978, 299:1215-1220.
62. Pisa EK, Pisa P, Kang HI, et al.: High frequency of t(14;18) translocation in salivary gland lymphomas from Sjogren's syndrome patients. J Exp Med 1991, 174:1245-1250.
63. Tzioufas AG, Boumba DS, Skopouli FN, et al.: Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjogren's syndrome. Arthritis Rheum 1996, 39:767-772.
64. Pettersson T, Pukkala E, Teppo L, et al.: Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis 1992, 51:437-439.
65. Mellemkjaer L, Andersen V, Linet MS, et al.: Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum 1997, 40:761-768.
66. Ramsey-Goldman R, Mattai SA, Schilling E, et al.: Increased risk of malignancy in patients with systemic lupus erythematosus. J Invest Med 1998, 46:217-222.
67. Cibere J, Sibley J, Haga M: Systemic lupus erythematosus and the risk of malignancy. Lupus 2001, 10:394-400.
68. Bjornadal L, Lofstrom B, Yin L, et al.: Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 2002, 31:66-71.
69. Sweeney DM, Manzi S, Janosky J, et al.: Risk of malignancy in women with systemic lupus erythematosus. J Rheumatol 1995, 22:1478-1482.
70. Abu-Shakra M, Gladman DD, Urowitz MB: Malignancy in systemic lupus erythematosus. Arthritis Rheum 1996, 39:1050-1054.
71. Sultan SM, Ioannou Y, Isenberg DA: Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review. Rheumatology (Oxford) 2000, 39:1147-1152.
72. Nived O, Bengtsson A, Jonsen A, et al.: Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden. Lupus 2001, 10:500-504.
73. Blumenfeld Z, Lorber M, Yoffe N, et al.: Systemic lupus erythematosus: pre-disposition for uterine cervical dysplasia. Lupus 1994, 3:59-61.
74. Talar-Williams C, Hijazi YM, Walther MM, et al.: Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med 1996, 124:477-484.
75. Hoffman GS, Kerr GS, Leavitt RY, et al.: Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992, 116:488-498.
76. Knight A, Askling J, Ekbom A: Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis. Int J Cancer 2002, 100:82-85.
77. Lindelof B, Sigurgeirsson B, Gabel H, et al.: Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000, 143:513-519.
78. Sigurgeirsson B, Lindelof B, Edhag O, et al.: Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study. N Engl J Med 1992, 326:363-367.
79. Chow WH, Gridley G, Mellemkjaer L, et al.: Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control 1995, 6:9-13.
80. Hill CL, Zhang Y, Sigurgeirsson B, et al.: Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001, 357:96-100.
81. Zantos D, Zhang Y, Felson D: The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol 1994, 21:1855-1859.
82. International Agency for Research on Cancer: Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42. IARC monographs on the evaluation of carcinogenic risks to humans. Suppl 7. Lyon, France: IARC publication, 1987.
83. International Agency for Research on Cancer: Evaluation of carcinogenic risks to humans. Silica, some silicates, coal dusts, and para-aramid fibrils. Vol. 68. Lyon, France: IARC publication, 1997.
84. International Agency for Research on Cancer: IARC monographs on the evaluation of carcinogenic risks to humans. Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. Vol. 58. Lyon, France: IARC publication, 1993.
85. Mossman BT, Gee JB: Asbestos-related diseases. N Engl J Med 1989, 320:1721-1730.
86. Kishimoto T, Okada K: The relationship between lung cancer and asbestos exposure. Chest 1988, 94:486-490.
87. Lash TL, Crouch EA, Green LC: A meta-analysis of the relation between cumulative exposure to asbestos and relative risk of lung cancer. Occup Environ Med 1997, 54:254-263.
88. Stayner LT, Dankovic DA, Lemen RA: Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis. Am J Public Health 1996, 86:179-186.
89. Saracci R: Asbestos and lung cancer: an analysis of the epidemiological evidence on the asbestos-smoking interaction. Int J Cancer 1977, 20:323-331.
90. Hammond EC, Selikoff IJ, Seidman H: Asbestos exposure, cigarette smoking and death rates. Ann N Y Acad Sci 1979, 330:473-490.
91. Lee PN: Relation between exposure to asbestos and smoking jointly and the risk of lung cancer. Occup Environ Med 2001, 58:145-153.
92. Whitwell F, Newhouse ML, Bennett DR: A study of the histological cell types of lung cancer in workers suffering from asbestosis in the United Kingdom. Br J Ind Med 1974, 31:298-303.
93. Johansson L, Albin M, Jakobsson K, et al.: Histological type of lung carcinoma in asbestos cement workers and matched controls. Br J Ind Med 1992, 49:626-630.
94. Mollo F, Pira E, Piolatto G, et al.: Lung adenocarcinoma and indicators of asbestos exposure. Int J Cancer 1995, 60:289-293.
95. Roggli VL, Pratt PC, Brody AR: Asbestos content of lung tissue in asbestos associated diseases: a study of 110 cases. Br J Ind Med 1986, 43:18-28.
96. Karjalainen A, Anttila S, Heikkila L, et al: Lobe of origin of lung cancer among asbestos-exposed patients with or without diffuse interstitial fibrosis. Scand J Work Environ Health 1993, 19:102-107.
97. Warnock ML, Isenberg W: Asbestos burden and the pathology of lung cancer. Chest 1986, 89:20-26.
98. Nuorva K, Makitara R, Huhti E, et al.: p53 protein accumulation in lung carcinomas of patients exposed to asbestos and tobacco smoke. Am J Respir Crit Care Med 1994, 150:528-533.
99. Churg A: Asbestos, asbestosis, and lung cancer. Mod Pathol 1993, 6:509-511.
100. Weiss W: Asbestos-related pleural plaques and lung cancer. Chest 1993, 103:1854-1859.
101. Weiss W: Asbestosis: a marker for the increased risk of lung cancer among workers exposed to asbestos. Chest 1999, 115:536-549.
102. Lee BW, Wain JC, Kelsey KT, et al.: Association of cigarette smoking and asbestos exposure with location and histology of lung cancer. Am J Respir Crit Care Med 1998, 157:748-755.
103. Roggli VL, Hammar SP, Pratt PC, et al.: Does asbestos or asbestosis cause carcinoma of the lung? Am J Ind Med 1994, 26:835-838.
104. Abraham JL: Asbestos inhalation, not asbestosis, causes lung cancer. Am J Ind Med 1994, 26:839-842.
105. Ribak J, Lilis R, Suzuki Y, et al.: Malignant mesothelioma in a cohort of asbestos insulation workers: clinical presentation, diagnosis, and causes of death. Br J Ind Med 1988, 45:182-187.
106. Browne K, Gee JB: Asbestos exposure and laryngeal cancer. Ann Occup Hyg 2000, 44:239-250.
107. Gerhardsson de Verdier M, Plato N, Steineck G, et al.: Occupational exposures and cancer of the colon and rectum. Am J Ind Med 1992, 22:291-303.
108. Weiss W: The lack of causality between asbestos and colorectal cancer. J Occup Environ Med 1995, 37:1364-1373.
109. Amandus H, Costello J: Silicosis and lung cancer in U.S. metal miners. Arch Environ Health 1991, 46:82-89.
110. Tornling G, Hogstedt C, Westerholm P: Lung cancer incidence among Swedish ceramic workers with silicosis. IARC Sci Publ 1990, 113-119.
111. Attfield MD, Costello J: Quantitative exposure-response for silica dust and lung cancer in Vermont granite workers. Am J Ind Med 2004, 45:129-138.
112. Sherson D, Svane O, Lynge E: Cancer incidence among foundry workers in Denmark. Arch Environ Health 1991, 46:75-81.
113. Dubrow R, Wegman DH: Cancer and occupation in Massachusetts: a death certificate study. Am J Ind Med 1984, 6:207-230.
114. Siemiatycki J, Gerin M, Dewar R, et al.: Silica and cancer associations from a multicancer occupational exposure case-referent study. IARC Sci Publ 1990, 29-42.
115. Steenland K, Mannetje A, Boffetta P, et al.: Pooled exposure-response analyses and risk assessment for lung cancer in 10 cohorts of silica-exposed workers: an IARC multicentre study. Cancer Causes Control 2001, 12:773-784.
116. Hughes JM, Weill H, Rando RJ, et al.: Cohort mortality study of North American industrial sand workers: II. Case-referent analysis of lung cancer and silicosis deaths. Ann Occup Hyg 2001, 45:201-207.
117. Siemiatycki J, Wacholder S, Dewar R, et al.: Degree of confounding bias related to smoking, ethnic group, and socioeconomic status in estimates of the associations between occupation and cancer. J Occup Med 1988, 30:617-625.
118. Katabami M, Dosaka-Akita H, Honma K, et al.: Pneumoconiosis-related lung cancers: preferential occurrence from diffuse interstitial fibrosis-type pneumoconiosis. Am J Respir Crit Care Med 2000, 162:295-300.
119. Calvert GM, Rice FL, Boiano JM, et al.: Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med 2003, 60:122-129.
120. Steenland K, Ward E: Lung cancer incidence among patients with beryllium disease: a cohort mortality study. J Natl Cancer Inst 1991, 83:1380-1385.
121. Ward E, Okun A, Ruder A, et al.: A mortality study of workers at seven beryllium processing plants. Am J Ind Med 1992, 22:885-904.
122. Sanderson WT, Ward EM, Steenland K, et al.: Lung cancer case-control study of beryllium workers. Am J Ind Med 2001, 39:133-144.
123. Falk HL, Jurgelski W Jr: Health effects of coal mining and combustion: carcinogens and cofactors. Environ Health Perspect 1979, 33:203-226.
124. Swaen GM, Meijers JM, Slangen JJ: Risk of gastric cancer in pneumoconiotic coal miners and the effect of respiratory impairment. Occup Environ Med 1995, 52:606-610.
125. Vallyathan V, Green FH, Rodman NF, et al: Lung carcinoma by histologic type in coal miners. Arch Pathol Lab Med 1985, 109:419-423.